Kejariwal D
Norfolk and Norwich, University Hospital, Colney Lane, Norwich NR4 7UY, UK.
J Bone Joint Surg Br. 2006 Mar;88(3):392-3. doi: 10.1302/0301-620X.88B3.17427.
Heparin is a drug widely used for thromboprophylaxis or treatment in many clinical situations. However, it can cause serious adverse effects, including thrombocytopenia, which is a potentially life-threatening condition. Unfortunately, heparin-induced thrombocytopenia is generally under-recognised and under-diagnosed. A case of heparin-induced thrombocytopenia occurring in a post-operative orthopaedic patient in association with prophylactic low-molecular-weight heparin is described.
肝素是一种在许多临床情况下广泛用于血栓预防或治疗的药物。然而，它可引起严重不良反应，包括血小板减少症，这是一种潜在的危及生命的病症。不幸的是，肝素诱导的血小板减少症通常未得到充分认识和诊断。本文描述了一例骨科术后患者发生的与预防性低分子量肝素相关的肝素诱导的血小板减少症病例。
